E
180 Life Sciences Corp. ATNF
$1.08 -$0.09-7.69%
Recommendation
Sell
Prev Close
$1.17
Volume
19,696
Avg Vol (90D)
336,098
Market Cap
$3.72M
Dividend & Yield
--
52-Week Range
$1.06 - $17.75
P/E (TTM)
--
EPS (TTM)
-$4.49
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Weiss Ratings Reiterates "Sell (E+)" Rating for 180 Life Sciences (NASDAQ:ATNF)
2/21/2025 - Ticker Report
Anson Funds Management LP Acquires Shares in 180 Life Sciences Corp
2/15/2025 - GuruFocus
180 Life Sciences Appoints New CEO Amid Leadership Changes
2/7/2025 - TipRanks Financial Blog
180 Life Sciences (NASDAQ:ATNF) Earns "Sell (E+)" Rating from Weiss Ratings
2/4/2025 - Ticker Report
Weiss Ratings Reaffirms Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF)
1/20/2025 - Ticker Report
180 Life Sciences Announces Key Proposals and Director Elections
12/31/2024 - TipRanks Financial Blog
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Up 148.1% in December
12/29/2024 - Ticker Report
180 Life Sciences Corp. Announces Pricing of $2. ...
12/27/2024 - GuruFocus
180 Life Sciences announces pricing of $2.9M registered direct offering
12/27/2024 - SeekingAlpha.com: All News
180 Life Sciences announces pricing of $2.9M registered direct offering
12/27/2024 - Seeking Alpha - Healthcare
180 Life Sciences prices $2.9M registered direct offering at $2.41 per share
12/27/2024 - TipRanks Financial Blog
180 Life Sciences prices $2.9M registered direct offering at $2.41 per share
12/27/2024 - The Fly
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
12/27/2024 - Accesswire
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
12/12/2024 - GuruFocus
180 Life Sciences regains compliance with Nasdaq listing rule
12/12/2024 - TipRanks Financial Blog
180 Life Sciences regains compliance with Nasdaq listing rule
12/12/2024 - The Fly
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
12/12/2024 - Accesswire
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
12/4/2024 - GuruFocus
180 Life Sciences appoints Stephen Shoemaker to board of directors
12/4/2024 - TipRanks Financial Blog
180 Life Sciences appoints Stephen Shoemaker to board of directors
12/4/2024 - The Fly
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
12/4/2024 - Accesswire
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Decreases By 34.9%
11/29/2024 - Ticker Report
180 Life Sciences files to sell 1.9M shares of common stock for holders
11/15/2024 - The Fly
ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences Corp
11/15/2024 - GuruFocus
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Update
11/14/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$6.29M
EBIT (TTM)
-$6.37M
Net Income (TTM)
-$3.12M
Balance Sheet
Total Assets (Q)
$10.47M
Total Debt (Q)
$483.70K
Total Liabilities (Q)
$6.74M
Book Value Per Share (Q)
$3.64
Cash Flow
Cash from Operations (TTM)
-$2.69M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$463.00K
Net Change in Cash (TTM)
-$2.47M
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Loading...
Beta
1.29
7-Day Total Return
-7.69%
30-Day Total Return
-23.40%
60-Day Total Return
-42.55%
90-Day Total Return
-72.52%
Year to Date Total Return
-37.21%
1-Year Total Return
-69.83%
2-Year Total Return
-97.67%
3-Year Total Return
-99.89%
5-Year Total Return
-99.97%
52-week Low
Mar 11, 2025 - $1.06
52-week High
Oct 16, 2024 - $17.75
Valuation
Market Cap
$3.72M - Nano Cap
Enterprise Value
$4.01M
Price/Sales (TTM)
--
Price/Book (Q)
0.32
Dividends and Shares
Shares Outstanding
980.60K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
180lifesciences.com
Phone Number
650 507 0669
Address
Building 4
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory... more
NASDAQ 03/13/2025 3:59PM Eastern Quotes delayed
Weiss Ratings